Transferrin and insulin enhance human colon tumor cell growth by differentiation class specific mechanisms

Oncology Research

Volumn 8, Issue 7-8, 1996, Pages 273-279

  Yeoman, Lynn C ^a   Wan, Ching Wah ^a   Zorbas, Mark A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

colon; EGF; receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN; TRANSFERRIN;

ARTICLE; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; COLON TUMOR; CONCENTRATION RESPONSE; DISSOCIATION CONSTANT; GROWTH REGULATION; HUMAN; HUMAN CELL; IMMUNOPOTENTIATION; IMMUNOREGULATION; PRIORITY JOURNAL; RECEPTOR OCCUPANCY; REGULATORY MECHANISM;

EID: 0029834764     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 1. Brattain, M. G.; Fine, W. D.; Khaled, F. M.; Thompson, J.; Brattain, D. E. Heterogeneity of malignant cells from a human colon carcinoma. Cancer Res. 41:1751-1756; 1981.
2. 2. Taylor, C. W.; Brattain, M. G.; Yeoman, L. C. Rate of growth and extent of differentiation reflected by cytoplasmic proteins and antigens of human colon tumor cell lines. Cancer Res. 44:1200-1205; 1984.
3. 3. Brattain, M. G.; Marks, M. E.; McCombs, J.; Fine, W.; Brattain, D. E. Characterization of human colon carcinoma cell lines isolated from a single primary tumour. Br. J. Cancer 47:373-381; 1983.
4. 4. Wan, C.-W.; McKnight, M. K.; Brattain, D. E.; Brattain, M. G.; Yeoman, L. C. Different epidermal growth factor growth responses and receptor levels in human colon carcinoma cell lines. Cancer Letters 43:139-143; 1988.
5. 5. Hoosein, N.; Brattain, D. E.; Matthews, K.; Levine, A. E.; Brattain, M. G. Characterization of the inhibitory effects of beta-TGF on a human colon carcinoma cell line. Cancer Res. 47:2950-2954; 1987.
6. 6. New, B. A.; Yeoman, L. C. Identification of basic fibroblast growth factor sensitivity and receptor and ligand expression in human colon tumor cell lines. J. Cell. Phys. 150:320-326; 1992.
7. 7. Zachary, I.; Rozengurt, E. Modulation of the epidermal growth factor receptor by mitogenic ligands: effects of bombesin and role of protein kinase C. Cancer Surv. 4:729-765; 1985.
8. 8. Gross, M. E.; Zorbas, M. A.; Danels, Y. J.; Garcia, R.; Gallick, G. E.; Olive, M.; Brattain, B. M.; Boman, B. M.; Yeoman, L. C. Cellular growth response to epidermal growth factor in colon carcinoma cells with an amplified epidermal growth factor receptor derived from a familial adenomatous polyposis patient. Cancer Res. 51: 1452-1459; 1991.
9. 9. Wiley, H. S.; Walsh, B. J.; Lund, K. A. Global modulation of the epidermal growth factor receptor is triggered by occupancy of only a few receptors; evidence for a binary regulatory system in normal human fibroblasts. J. Biol. Chem. 264:18912-18920; 1989.
10. 10. Briere, N.; Ferrari, J.; Chailler, P. Synergistic influence of epidermal growth factor, insulin and transferrin on human fetal kidney cultures. Biofactors 3:113-120; 1991.
11. 11. Krane, J. F., Murphy, D. P., Carter, D. M.; Krueger, J. G. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J. Invest. Derm. 96:419-424; 1991.
12. 12. Shi, Y. E.; Yager, J. D. Effects of the liver tumor promoter ethinyl estradiol on epidermal growth factor-induced DNA synthesis and epidermal growth factor receptor levels in cultured rat hepatocytes. Cancer Res. 49: 3574-3580; 1989.
13. 13. Mukku, V. R. Regulation of epidermal growth factor receptor levels by throid hormone. J. Biol. Chem. 259: 6543-6547; 1984.
14. 14. Mulder, K. M.; Brattain, M. G. Effects of growth stimulatory factors on mitogenicity and c-myc expression in poorly differentiated and well differentiated human colon carcinoma cells. Mol. Endocrinol. 3:1215-1222; 1988.
15. 15. Boyd, D. D.; Levine, A. E.; Brattain, D. E.; McKnight, M. K.; Brattain, M. G. A comparison of growth requirements of two human intratumoral colon carcinoma cell lines in monolayer and soft agarose. Cancer Res. 48: 2469-2474; 1988.
16. 16. Watkins, L. F.; Lewis, L. R.; Levine, A. E. Characterization of the synergistic effect of insulin and transferrin and the regulation of their receptors on a human colon carcinoma cell line. Int. J. Cancer 45: 372-375; 1990.
17. 17. Marks, M. E.; Danbury, B. H.; Miller, C. A.; Brattain, M. G. Cell surface proteins and glycoproteins from biologically different human colon carcinoma cell lines. J. Natl. Cancer Inst. 71:663-671; 1983.
18. 18. Hunter, W. M.; Greenwood, F. C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 194:495-496; 1962.
19. 125I-labeled epidermal growth factor to human fibroblasts. J. Biol. Chem. 255: 1239-1241; 1980.
20. 20. Carpenter, G.; Lembach, K. J.; Morrison, M. M.; Cohen, S. Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J. Biol. Chem. 25:4297-4304; 1975.
21. 21. Scatchard, G. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51:660-672; 1949.
22. 22. McPherson, G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Prog. Biomed. 17:107-114; 1983.
23. 23. Kawamoto, T.; Mendelsohn, J.; Le, A.; Sato, G. H.; Lazar, C. S.; Gill, G. N. Relation of epidermal growth factor receptor concentration to the growth of human epidermoid carcinoma A431 cells. J. Biol. Chem. 259:7761-7766; 1984.
24. 24. Krupp, M. N.; Connolly, D. T.; Lane, M. D. Synthesis, turnover, and downregulation of epidermal growth factor receptors in human A431 epidermoid carcinoma cells and skin fibroblasts. J. Biol. Chem. 257:11489-11496; 1982.
25. 25. Collins, M. K.; Sinnett-Smith, J. W.; Rozengurt, E. Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells. J. Biol. Chem. 258:11689-11693; 1983.
26. 26. Winston, J. T.; Olashaw, N. E.; Pledger, W. J. Regulation of the transmodulated epidermal growth factor receptor by cholera toxin and the protein phosphatase inhibitor okadaic acid. J. Cell. Biochem. 47:79-89; 1991.
27. 27. Bowen-Pope, D. E.; DiCorletto, P. E.; Ross, R. Interactions between the receptors for platelet-derived growth factor and epidermal growth factor. J. Cell Biol. 96:679-683; 1983.
28. 28. Countaway, J. L.; Northwood, I. C.; Davis, R. J. Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669. J. Biol. Chem. 264:10828-10835; 1989.
29. 29. Walker, F.; Burgess A. W. Transmodulation of the epidermal growth-factor receptor in permeabilized 3T3 cells. Biochem. J. 256:109-115; 1988.
30. 30. Krane, J. F.; Murphy, D. P; Carter, D. M.; Krueger, J. G. Synergistic effects of epidermal growth factor (EGF) and insulin-like growth factor I/somatomedin C (IGF-I) on keratinocyte proliferation may be mediated by IGF-I transmodulation of the EGF receptor. J. Invest. Dermatol. 96:419-424; 1991.
31. 31. Bird, T. A.; Saklatvala J. IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism. J. Immunol. 142:126-133; 1989.
32. 32. Zorbas, M. A.; Yeoman, L. C. Growth control in a human colon carcinoma cell line mediated by cell-associated transforming growth factor-α (TGF-α). Exptl. Cell Res. 206:49-57; 1993.